MYmAb Biologics Recognized as a BioNexus Status Company
March 2025 – We are thrilled to announce that MYmAb Biologics has been awarded BioNexus Status by the Bioeconomy Corporation. This prestigious recognition marks a significant milestone in our mission to drive life sciences innovation in Malaysia and beyond.
What is the BioNexus Status?

The BioNexus Status is a special recognition awarded by the Malaysian Bioeconomy Corporation to biotechnology companies that demonstrate exceptional potential in research, innovation, and commercialization. It provides access to various incentives, funding opportunities and strategic support, fostering the growth of biotech enterprises in Malaysia.
How Does BioNexus Status Benefits MYmAb Biologics?
Achieving BioNexus Status reinforces MYmAb Biologics’ commitment to advancing Tissue Microarray (TMA) technology and providing high-quality, ethically sourced Southeast Asian tissue samples for oncology research and precision medicine.
As a BioNexus Status Company, we will benefit from:
- Enhanced R&D Capabilities: Access to incentives will strengthen our in-house innovation and biomedical advancements.
- Stronger Industry Collaboration: We aim to expand our partnerships with industry leaders, researchers, and healthcare professionals to drive impactful research.
- Accelerated Scientific Progress: With strategic support, we can further develop novel research tools, bridging the gap between scientific discovery and real-world patient care.
Looking Ahead
Our ultimate goal is to make clinical research more inclusive and accessible, ensuring that Southeast Asian genetic diversity is well represented in cancer research and precision medicine. We extend our deepest gratitude to our dedicated team, partners, and stakeholders who have supported us on this journey.
This is just the beginning—stay tuned as we continue to push the boundaries of biomedical innovation!
If you are a researcher or organization looking for high-quality tissue microarray, or exploring collaboration opportunities, we would love to connect with you. Reach out to us!